Single antiplatelet therapy for patients with previous gastrointestinal bleeds

Annals of Pharmacotherapy

Volumn 42, Issue 6, 2008, Pages 836-840

  Gellatly, Rochelle M ^a   Ackman, Margaret L ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Regional Pharmacy Services   (Canada)

^c Capital Health Edmonton   (Canada)

Author keywords

Aspirin; Clopidogrel; Gastrointestinal bleed; Proton pump inhibitor

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; ESOMEPRAZOLE; FAMOTIDINE; PROTON PUMP INHIBITOR;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL HEMORRHAGE; HUMAN; PRIORITY JOURNAL; SECONDARY PREVENTION;

AGED; ASPIRIN; CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TICLOPIDINE;

EID: 44649184107     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1K566     Document Type: Article

References (15)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
2. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
3. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000;321:1183-7.
4. McQuaid KR, Laine L. Systematic review and meta analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med 2006;119:624-38.
5. Laine L. Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk? Aliment Pharmacol Ther 2006;24:897-908.
6. Lanas A, Garcia-Rodriguez LA, Arroyo MT, et al., on behalf of the investigators of the Asociacion Espanola de Gastroenterologia. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 2006;55:1731-8.
7. Ng FH, Wong SY, Chang CM, et al. High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther 2003;18:443-9.
8. Fraker TD, Fihn SD, on behalf of the 2002 Chronic Stable Angina Writing Committee. 2007 Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Catdiol 2007;50:2264-74.
9. Harrington RA, Becker RC, Ezekowitz M, et al. Antithrombotic therapy for coronary artery disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126(suppl 3):513S-48S.
10. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. Circulation 2007;116:e148-e304.
11. Chan F, Ching J, Hung L, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med 2005;352:238-44.
12. Lai K, Chu K, Hui W, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol 2006;4:860-5.
13. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
14. Anand BS, Sanduja SK, Lichtenberger LM. Effect of omeprazole on the bioavailability of aspirin: a randomized controlled study on healthy volunteers (abstract). Gastroenterology 1999;116:A371.
15. Inarrea P, Esteva F, Cornudella R, Lanas A. Omeprazole does not interfere with the antiplatelet effect of low-dose aspirin in man. Scand J Gastroenterol 2000;35:242-6.